Navigation Links
ABC News NIGHTLINE Features HIFU with Sonablate(R) 500 as Non Invasive Treatment Option for Prostate Cancer
Date:6/27/2008

Segment fails to mention ongoing FDA-approved HIFU clinical trials in the United States and abundant clinical data on HIFU outcomes and experience

CHARLOTTE, N.C., June 27 /PRNewswire/ -- USHIFU, LLC, the exclusive distributor of the minimally invasive Sonablate(R) 500 for prostate cancer treatment in North and South America, announced that the June 16, 2008 edition of ABC News NIGHTLINE featured a segment on high intensity focused ultrasound (HIFU) for treating prostate cancer outside of the United States using the Sonablate(R) 500.

According to the segment, men diagnosed with prostate cancer have the ability to travel outside of the United States to receive HIFU, a non invasive, outpatient procedure for prostate cancer.

The segment failed to mention that the Sonablate(R) 500 HIFU treatment is currently involved in two different FDA-approved clinical trials in the United States to gather data important for analysis of the technology by the FDA. The first is a pivotal trial for the treatment of primary organ confined prostate cancer that will enroll 466 participants at 24 different centers. A second pivotal trial will begin for the treatment of recurrent prostate cancer in men who have failed external beam radiation therapy.

Dr. Herbert Lepor, Chairman of Urology at NYU School of Medicine and medical monitor for the trials said, "I have personally reviewed the preliminary data and observed the Sonablate(R) 500 in action and I am impressed with this advanced technology for ablating the prostate. These rigorous clinical trials will add to the international data already available and will further help define the appropriate role of the Sonablate(R) 500 device in the treatment of prostate cancer," Lepor added.

If patients meet the enrollment criteria they may qualify to enroll in the U.S. HIFU clinical trials. For more information about the clinical trials eligibility criteria call USHIFU at 1-877-874-4389.

"HIFU offers no
'/>"/>

SOURCE USHIFU, LLC
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine technology :

1. PositiveFriends.com Launches STD Social Networking Site Balancing Dating with Online Support Features
2. Mayo Clinic Studies Find REM Sleep Behavior Disorder is Associated with Other Features of Neurodegenerative Disorders
3. Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
4. New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results
5. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
6. New Minimally Invasive Breast Reconstructive Procedure for Breast Cancer Patients - Actively Recruiting Participants for Clinical Study
7. New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns
8. Minimally Invasive Treatment Reduces Shoulder Pain From Tendonitis
9. Positive Results Published Using AtriCure Minimally Invasive Products
10. Independent Clinical Results Confirm Up to a 7-Centimeter Reduction in Body Circumference Using UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring System
11. UltraShape(R) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Featured at American Society for Laser Medicine and Surgery Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)..., Nov. 20 Clinical data from a pro... Annual Veith Symposium shows DVT,treatment with ...chus,Vascular, Inc. (Santa Clara, CA) successfull...out 20 minutes. , This technique, called is...blood flow more quickly and safely than current ca...
(Date:11/19/2008)..., Study did not achieve statistical significance...stCall/ -- Pharmos Corporation (Nasdaq: PARS ) t...trial of its topical NanoEmulsion (NE) drug delive...nolamine. , , The multi-center, randomized,...d the safety and efficacy of the Company,s 3% Dicl...
(Date:11/18/2008)...November 19 NeuroDiscove...ce provider and drug development Company,and Sos...4565), a leading,international biopharmaceutical ...esenting further pivotal pre-clinical efficacy dat... a potential therapy for neuropathic pain and has,...
(Date:11/18/2008)...ed study will enroll newly diagnosed, elderly AML ...wswire/ -- Celator Pharmaceuticals today announced...omized Phase 2 clinical study of CPX-351 (Cytarabi...th newly diagnosed acute myeloid leukemia (AML). ,...eldman, MD at the Weill Medical College of Cornel...
Breaking Medicine Technology:Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3Quigley Anti Viral Compound QR448 28a 29 Successfully Prevents Transmission of Infectious Bronchitis in Chickens 3068 1Quigley Anti Viral Compound QR448 28a 29 Successfully Prevents Transmission of Infectious Bronchitis in Chickens 3068 2Quigley Anti Viral Compound QR448 28a 29 Successfully Prevents Transmission of Infectious Bronchitis in Chickens 3068 3Quigley Anti Viral Compound QR448 28a 29 Successfully Prevents Transmission of Infectious Bronchitis in Chickens 3068 4ProSource 2 0 Offers Value Savings for Lab Supplies 7714 1ProSource 2 0 Offers Value Savings for Lab Supplies 7714 2Why some primates but not humans can live with immunodeficiency viruses and not progress to AIDS 4907 1Why some primates but not humans can live with immunodeficiency viruses and not progress to AIDS 4907 2Why some primates but not humans can live with immunodeficiency viruses and not progress to AIDS 4907 3Why some primates but not humans can live with immunodeficiency viruses and not progress to AIDS 4907 4Sir David Lane honored with Royal Gold Medal by Royal Society of Edinburgh 4902 1
(Date:11/21/2008)...ning increases production of neural stem cells , ...experiments in mice, exercise appears to reverse t...sually seen with aging, Taiwanese researchers repo...s ability to stave off aging appears to be due to ... is essential for the production of new brain cell...
(Date:11/21/2008)...re/ -- For the second year in a row and the thir... Worldwide,s agency network won more creative awar...l international RX Club Show. , , Nine McC...l of 59 RX Club Awards of Excellence, including a ... Worldwide agencies include Caudex Medical, echo T...
(Date:11/21/2008)... -- Innerscope Research(TM), a revolutionary,biom...l Response Measurement,announced today the appoi...,company,s research and development, business str...ee appointments, who deliver a combined 60 years o...ncial Officer and Vice President of,Strategy; Dr....
(Date:11/21/2008)...(Nov. 21, 2008) How can moss help us to treat Al...stem tell us about evolution? Can genetic studies...nserve rare species? What can quail teach us abou...es? Will studies of choanoflagellates unravel the... questions in biology, scientists are increasing t...
Breaking Medicine News(10 mins):Health News:Exercise Keeps the Brain Young 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 3Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 4Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2Health News:A new world of research possibilities with 'Emerging Model Organisms' 2
... is a wonder hormone which is discovered around 19...ch as to controls appetite, burns calories// and p... But the actual mechanism or mode of action throug...ic activities were not known till date. Now, resea...
...ists are now monitoring data human welfare, spread...ote sensing technology and satellite imagery in or...al systems//. Doug Goodin, the geography profess...a satellite imagery to enable the study of changes...
...ntre for Mental Health Research at ANU has planned...ntal illness as a result of drug and alcohol use//...stensen, is one of five selected in the latest rou...alian Primary Health Care Research Institute (APHC...
... McEwen Centre for Regenerative Medicine, Toronto ...distress signal that induces the mobilization //of... affected heart after an attack. While it has lon...ve the ability to clear the dead tissue after a he...
Other Medicine News:Health News:How Does Leptin Work? 2Health News:Ecological Changes affects human health, food security 2Health News:Funding Approved for Research into Primary Health Care 2Health News:Bone Marrow Cells Aid In Heart Repair 2Health News:Bone Marrow Cells Aid In Heart Repair 3
...y and lower cost per test for the clinical lab. ,...ecks in the busy clinical lab... the new StatSpin ...fuge spins standard 5 mL blood collection tubes in...r plasma equal to 10-15 minute runs in larger, mor...
...stem for performing fast, clean, safe and accurate...em is microprocessor controlled to automatically s...e. At the end of the cycle, the urine sediment is ...roscopic analysis.,The CenSlide Urinalysis Sy...
Used to provide drainage of urine from the bladder. All-silicone construction provides maximum softness and biocompatibility for enhanced patient comfort. Supplied sterile in peel-open packages. Inte
Used for temporary internal drainage from the ureteropelvic junction to the bladder. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is advised; polyur
Medicine Products: